TipRanks
Go Ultimate55% OFF

Cytokinetics (CYTK) Revenue by Segment

Revenue by Segment

Highlights revenue contributions from different business segments, providing insight into which areas drive growth and how diversified the company’s income streams are.

$0.00$20.00M$40.00M$60.00M$80.00MMar 21Jun 21Sep 21Dec 21Mar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26
Chart Insights

Historically Cytokinetics’ top line was lumpy—license and milestone receipts drove episodic spikes while product revenue was essentially zero until Q1 2026. The ~$4.8M of net product revenue plus a Bayer milestone mark the start of recurring commercial income and are backed by encouraging early prescribing, but access is still scaling and Acacia HCM safety observations plus heavy launch/SG&A spend mean near‑term volatility; sustainable upside hinges on payer parity, expanded prescriber uptake, and upcoming regulatory readouts.

CYTK Revenue by Segment

DateOtherNet ProductLicenseResearch and DevelopmentMilestone
Jun 30, 2026$0.00$25.33M$0.00$3.29M$0.00
Mar 31, 2026$0.00$4.79M$11.93M$2.64M$0.00
Dec 31, 2025$0.00$0.00$0.00$2.75M$15.00M
Sep 30, 2025$0.00$0.00$0.00$1.94M$0.00
Jun 30, 2025$0.00$0.00$64.35M$2.42M$0.00
Mar 31, 2025$0.00$0.00$0.00$1.58M$0.00
Dec 31, 2024$0.00$0.00$0.00$1.93M$15.00M
Sep 30, 2024$0.00$0.00$0.00$463.00K$0.00
Jun 30, 2024$0.00$0.00$0.00$249.00K$0.00
Mar 31, 2024$0.00$0.00$0.00$835.00K$0.00
Dec 31, 2023$0.00$0.00$0.00$672.00K$1.00M
Sep 30, 2023$0.00$0.00$0.00$378.00K$0.00
Jun 30, 2023$0.00$0.00$0.00$867.00K$0.00
Mar 31, 2023$0.00$0.00$0.00$2.11M$2.50M
Dec 31, 2022$0.00$0.00$0.00$1.96M$0.00
Sep 30, 2022$0.00$0.00$0.00$2.52M$0.00
Jun 30, 2022$87.00M$0.00$0.00$968.00K$1.00M
Mar 31, 2022$0.00$0.00$0.00$1.15M$0.00
Dec 31, 2021$0.00$0.00$54.86M$744.00K$0.00
Sep 30, 2021$0.00$0.00$0.00$437.00K$5.00M
Jun 30, 2021$0.00$0.00$0.00$2.84M$0.00
Mar 31, 2021$0.00$0.00$0.00$6.55M$0.00
Dec 31, 2020$0.00$0.00$0.00$4.22M$2.50M
Sep 30, 2020$0.00$0.00$36.50M$5.19M$0.00
Jun 30, 2020$0.00$0.00$0.00$3.59M$0.00
Mar 31, 2020$0.00$0.00$0.00$38.25K$0.00